Drug maker scouting for Indian companies specializing in therapy segments such as nephrology and urology

Many shifting focus to emerging economies in struggle to stay afloat

Major Japanese pharmaceutical makers are expediting projects to construct plants and expand sales channels in emerging economies, such as China and India.

French drug manufacturing giant Sanofi-Aventis is stepping up its presence in the nonprescription drug market in the United States and Europe.

Seattle Genetics just scored a potentially big licensing deal with Big Pharma. The Bothell biotech company announced a collaboration agreement with GlaxoSmithKline that will give Glaxo rights to use its antibody-drug conjugate technology.